Quantum Biopharma Ltd.(QNTM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

QNTM Quantum Biopharma Ltd.

Trading 10-15 14:17:05 EDT

2.62

-0.04

-1.69%

High2.74	Low2.60	Vol63.45K
Open2.65	D1 Closing2.66	Amplitude5.26%
Mkt Cap21.15M	Tradable Cap20.01M	Total Shares8.09M
T/O168.19K	T/O Rate0.83%	Tradable Shares7.65M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"QNTM","market":"US","secType":"STK","nameCN":"Quantum Biopharma Ltd.","latestPrice":2.615,"timestamp":1792088216854,"preClose":2.66,"halted":0,"volume":63452,"delay":0,"changeRate":-0.016917293233082678,"floatShares":7650300,"shares":8087521,"eps":-5.353747,"marketStatus":"Trading","change":-0.045,"latestTime":"10-15 14:17:05 EDT","open":2.65,"high":2.74,"low":2.6,"amount":168192.53366,"amplitude":0.052632,"askPrice":2.63,"askSize":118,"bidPrice":2.6,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-5.353747,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1792094400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":2.66,"preHourTrading":{"tag":"盘前","latestPrice":2.66,"preClose":2.66,"latestTime":"09:29 EDT","volume":2730,"amount":7577.499110999999,"timestamp":1792070941093,"change":0,"changeRate":0,"amplitude":0.054173},"postHourTrading":{"tag":"盘后","latestPrice":2.75,"preClose":2.66,"latestTime":"19:30 EDT","volume":850,"amount":2345.9314,"timestamp":1792020606313,"change":0.09,"changeRate":0.033835,"amplitude":0.045113},"volumeRatio":0.679671},"requestUrl":"/m/hq/s/QNTM/wiki","defaultTab":"wiki","newsList":[{"id":"2673074770","title":"US Judge Consolidates Quantum BioPharma Stock-Manipulation Suits Against CIBC, RBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2673074770","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673074770?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:03","pubTimestamp":1791460988,"startTime":"0","endTime":"0","summary":"US judge consolidates Quantum BioPharma stock-manipulation suits against CIBC, RBCA US federal judge in Manhattan consolidated Quantum BioPharma’s lawsuit with a shareholder class action alleging stoc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL1dh5fY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","QNTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673072613","title":"World Renowned Law Firm Grant & Eisenhofer Appointed Lead Counsel In Newly Consolidated Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2673072613","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673072613?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460800,"startTime":"0","endTime":"0","summary":"TORONTO, Oct.  08, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/08/3377184/0/en/world-renowned-law-firm-grant-eisenhofer-appointed-lead-counsel-in-newly-consolidated-class-action-lawsuit-against-canadian-banks-cibc-and-rbc-alleging-illegal-stock-market-manipul.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DBB","QNTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673014784","title":"Quantum BioPharma (NASDAQ: QNTM) Enlists Thermo Fisher’s Clinical Research Business to Launch Phase 2 Lucid-MS Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673014784","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673014784?lang=en_us&edition=fundamental","pubTime":"2026-10-08 01:30","pubTimestamp":1791394209,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, October 7th, 2026, FinanceWire New agreement moves innovative Lucid-MS treatment from planning into execution. Propri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-enlists-thermo-fishers-clinical-research-business-to-launch-phase-2-lucid-ms-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-enlists-thermo-fishers-clinical-research-business-to-launch-phase-2-lucid-ms-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECS","LU0390134368.USD","BK4588","QYLG","LU1989772840.SGD","QQQE","03086","QQQA","QID","SQQQ","LU1732799900.SGD","LU1791710400.SGD","KBWB","LU0106831901.USD","QQQ","PSQ","LU2264538146.SGD","MNQmain","LU0210528500.USD","JEPQ","LU0098860793.USD","LU2111349929.HKD","NVIW.SI","IYW","QQQJ","TQQY","QNTM","LU0795875169.SGD","FTEC","BK4504","LU1720051108.HKD","QLD","GPIQ","QQQY","ONEQ","NDX","TQQQ","LU0912757837.SGD","LCDL","QDTE","LCID","LU2089284900.SGD","LCIZ","LU1244550221.USD","QQQM","NQmain","BK4007","IAI",".IXIC","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673050313","title":"Quantum BioPharma (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673050313","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673050313?lang=en_us&edition=fundamental","pubTime":"2026-10-07 00:30","pubTimestamp":1791304222,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, October 6th, 2026, FinanceWire Quantum BioPharma (NASDAQ:QNTM) entered into a Study Start-Up Agreement (“SUA&rd...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-enters-study-start-up-agreement-for-lucid-ms-phase-2-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-enters-study-start-up-agreement-for-lucid-ms-phase-2-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSQ","ONEQ","BK4596","QLD","LCID","TECS","QQQM","IYW","QDTE","QYLG",".IXIC","MNQmain","SQQQ","QNTM","QQQY","NVIW.SI","QQQA","NDX","QQQJ","QID","FTEC","QQQE","BK4007","GPIQ","BK4551","BK4099","JEPQ","NQmain","LCDL","LCIZ","03086","QQQ","TQQY","TQQQ","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673589610","title":"Quantum BioPharma signs contract with Thermo Fisher for sclerosis trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673589610","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673589610?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:11","pubTimestamp":1791281470,"startTime":"0","endTime":"0","summary":"Quantum BioPharma (QNTM) has entered into a Study Start-Up Agreement, or SUA, with the clinical research business of Thermo Fisher (TMO) to impleme...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quantum-biopharma-signs-contract-with-thermo-fisher-for-sclerosis-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quantum-biopharma-signs-contract-with-thermo-fisher-for-sclerosis-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0122379950.USD","LU0061474960.USD","LU0251131958.USD","IE0009355771.USD","LU2211814178.USD","BK4535","TMO","LU1923622614.USD","BK4534","LU2125909759.SGD","LU0342679015.USD","LU2360108059.USD","BK4121","LU2720916845.USD","LU0251142724.SGD","LU1854104046.USD","GNMX","LU0742534661.SGD","IE00BQXX3C00.GBP","LU1057294990.SGD","LU1923622291.USD","LU0096362180.USD","LU2468319806.SGD","LU2764263203.CNY","LU2089984988.USD","LU0320765489.SGD","LU2764262908.HKD","QNTM","GB00BDT5M118.USD","LU0048573561.USD","LU2092937221.SGD","LU2764263039.SGD","LU0266013472.USD","LU0070302665.USD","LU1670628061.USD","LU0234572021.USD","LU2125909593.SGD","TMED","LU0345770993.USD","LU1280957306.USD","LU0345770308.USD","LU2433249047.HKD","HRTS","IE00BJT1NW94.SGD","LU2298321311.HKD","LU2211815571.USD","LU1988902786.USD","LU0882574055.USD","LU0208291251.USD","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673605831","title":"Quantum BioPharma Signs Thermo Fisher Clinical Research Unit Contract to Launch Phase 2 MS Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673605831","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673605831?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:04","pubTimestamp":1791281060,"startTime":"0","endTime":"0","summary":"Quantum BioPharma signs Thermo Fisher clinical research unit contract to launch Phase 2 MS trialQuantum BioPharma signed a study start-up agreement with Thermo Fisher’s PPD clinical research unit to i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL64r1Tk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNTM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673030078","title":"Quantum Biopharma - Thermo Fisher to Support Phase 2 Lucid-MS Clinical Trial Implementation","url":"https://stock-news.laohu8.com/highlight/detail?id=2673030078","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673030078?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:00","pubTimestamp":1791280801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA73SDYM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["QNTM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670463425","title":"Quantum BioPharma (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2670463425","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670463425?lang=en_us&edition=fundamental","pubTime":"2026-09-25 23:30","pubTimestamp":1790350237,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, September 25th, 2026, FinanceWire The FDA IND approval marks a pivotal step for the company’s lead compound, kn...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-receives-fda-green-light-to-move-lucid-ms-into-phase-2-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-receives-fda-green-light-to-move-lucid-ms-into-phase-2-testing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["03086","MNQmain","LABU","QQQA","NVIW.SI","NQmain","IND","QYLG","QQQE","LCID","SQQQ","ONEQ","IYW","QNTM","QQQM","TQQQ","BK4007","QID","FTEC","QQQ","BK4551","BK4596","LCDL","BK4585","GPIQ",".IXIC","LCIZ","BK4099","TQQY","QQQY","TECS","QQQJ","JEPQ","QLD","BK4588","PSQ","QDTE","NDX","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669606454","title":"Quantum BioPharma Licensee Unbuzzd Names Michael Zapolin CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669606454","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669606454?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:02","pubTimestamp":1790251356,"startTime":"0","endTime":"0","summary":"Quantum BioPharma licensee Unbuzzd names Michael Zapolin CEOQuantum BioPharma’s licensee Unbuzzd Wellness appointed Michael Zapolin, known as “Zappy,” as CEO.Zapolin previously worked on Wall Street, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL2nvqhb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TFNS","IYF","LU2357305700.SGD","TRUF","LU0256863811.USD","LU0971096721.USD","UYG","JPO","LU0868494617.USD","IXG","LU2462157665.USD","LU2357627491.SGD","LU0006306889.USD","FTXO","LU0345769631.USD","SG9999002232.USD","LU0943347566.SGD","LU0157215616.USD","IYG","LU0964807845.USD","VFH","LU2756315318.SGD","FNCL","KBWB","LU0170899867.USD","LU2456880835.USD","IE00BZ1G4Q59.USD","BK4581","BK4550","IE00BHPRN162.USD","JPMO","LU2237443465.HKD","LU2552382132.HKD","BK4588","LU0310799852.SGD","LU1917777945.USD","XLF","QNTM","LU1894683264.USD","IE0034235303.USD","LU0267386448.USD","LU0106831901.USD","LU0417517546.SGD","LU0211328371.USD","IE00BKDWB100.SGD","IE00BLSP4452.SGD","LU0320765646.SGD","LU1366192091.USD","LU0211327993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669049397","title":"Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669049397","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669049397?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251200,"startTime":"0","endTime":"0","summary":"TORONTO, Sept.  24, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) (“Quantum BioPharma”), today announced its licensee – Unbuzzd Wellness Inc. (the \"Company\" or \"Unbuzzd\"),","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368265/0/en/quantum-biopharma-licensee-unbuzzd-wellness-to-advance-clinically-validated-alcohol-metabolism-accelerant-after-appointing-zappy-as-ceo.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNTM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669339394","title":"Quantum BioPharma (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2669339394","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669339394?lang=en_us&edition=fundamental","pubTime":"2026-09-24 02:00","pubTimestamp":1790186416,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, September 23rd, 2026, FinanceWire In the United States alone, close to one million people are living with MS, with a ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-pursues-a-new-path-for-better-multiple-sclerosis-treatments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-pursues-a-new-path-for-better-multiple-sclerosis-treatments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0971096721.USD","03086","LU1244550577.SGD","LU0390134368.USD","QQQY","TQQQ","BK4588","QLD","IE00BZ1G4Q59.USD","QQQJ","MNQmain","LU2271345857.HKD","NQmain","QQQM","GPIQ","LU1732800096.USD","LU1988902786.USD","PSQ","FTEC","QNTM",".IXIC","LU1363072403.SGD","NVIW.SI","LU0912757837.SGD","NDX","LU0158827948.USD","LU0006306889.USD","QQQA","IE00BKVL7J92.USD","QQQE","QYLG","LU1548497426.USD","LU1668664300.SGD","QDTE","LU2357305700.SGD","LU0106831901.USD","TECS","IE00B775SV38.USD","LU1074936037.SGD","IAI","LU2133065610.SGD","ONEQ","LU1989772923.USD","SQQQ","QID","JEPQ","IYW","QQQ","TQQY","KBWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669480817","title":"Inside Quantum World Congress: Where FBI Agents, Big Tech, and Stock Hype Converge","url":"https://stock-news.laohu8.com/highlight/detail?id=2669480817","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669480817?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:08","pubTimestamp":1790179680,"startTime":"0","endTime":"0","summary":"The quantum computing sector has seen no shortage of hype this year, and now one of the industry's largest gatherings is set to give stocks another push.Shares of quantum computing companies rallied i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","LU2347655073.USD","AIPI","IE00B3M56506.USD","SG9999000418.SGD","HK0000306701.USD","TEK","LU2065171402.SGD","LU0345769631.USD","LU1861127337.USD","LU2294711713.HKD","LU1674673428.USD","NVDL","LU0979878070.USD","IE00B775SV38.USD","2NVD.UK","IE00B19Z8X17.USD","IE00BDRTCR15.USD","LU0265550946.USD","CMAG","LU1989772923.USD","LU0124676726.USD","NVDA","NVII","LU0882574139.USD","BK4549","LU2237957811.SGD","LU0081259029.USD","BK4023","LU1917777945.USD","BK4533","LU1868836914.USD","NVDY","LU2125909916.SGD","BK4598","QBTZ","IE00BKPKM429.USD","LU2265009873.SGD","LU0256863902.USD","LU2237443978.SGD","LU2361044949.HKD","LU1496350171.SGD","LU1778281490.HKD","LU2065169927.USD","LU2462591350.SGD","LU0061475181.USD","LU2360106780.USD","LU0158827948.USD","LU0354030438.USD","BK4503","SG9999017495.SGD","LU0949170772.SGD","IE00BYXW3230.USD","LU2357125470.USD","SG9999004303.SGD","SNVDAmain","LU0289739343.SGD","LU2420271590.USD","LU0057025933.USD","LU2413666426.HKD","09388","LU0174119429.USD","LU0494093205.USD","SG9999002232.USD","BK4579","LU2746668974.SGD","LU2506951792.HKD","LU1951200564.SGD","LU1633808545.USD","LU1868837136.USD","LU1280957306.USD","LU0964807845.USD","LU2456880835.USD","LU2213496289.HKD","BK4141","NVDX","LU0472753341.HKD","LU0345768740.USD","LU0957791311.USD","LU0476273544.USD","DIPS","LU0070217475.USD","LU2089284900.SGD","LU0444971666.USD","LU0096362180.USD","METV","LU2637965513.SGD","LU2931357623.SGD","LU2237443622.USD","LU1323610961.USD","LU2249611893.SGD","LU1674673691.USD","LU2272731600.USD","LU0965509283.SGD","LU1934455863.HKD","LU1116320737.USD","LU1880398554.USD","LU0316494557.USD","LU0109392836.USD","LU2087625088.SGD","LU0353189763.USD","LU0672654240.SGD","LU1720051108.HKD","LU0738911758.USD","SG9999015945.SGD","IE00B1XK9C88.USD","LU0820561818.USD","09788","LU0211328371.USD","SG9999014575.USD","LU2286300806.USD","LU0545039389.USD","LU2602419157.SGD","LU0133085943.USD","IONQ","LU0097036916.USD","ROM","BK4585","LU1721428933.USD","THMR","LU0708994859.HKD","IE00B7KXQ091.USD","LU0417517546.SGD","LU2065170008.USD","LU0128525929.USD","BK4007","LU1992135399.USD","LU2430703095.HKD","LU2097344431.USD","LU1935043536.SGD","LU1069344957.HKD","BK4591","LU1066053197.SGD","LU0154236417.USD","QUA","IE0034235295.USD","LU2487616109.SGD","LU0689472784.USD","SNVD.UK","LU0985320562.USD","LU2746668461.USD","HK0000819398.USD","LU2458330243.SGD","ILDR","LU0912757837.SGD","LU2756315664.SGD","IE0034235188.USD","LU2168564222.USD","USD","BK4554","IE00B5949003.HKD","IE00BZ199S13.USD","LU2097344357.USD","BK4614","LU2065171311.SGD","IE00BK4W5M84.HKD","LU0557290698.USD","LU2413666699.HKD","LU1983260115.SGD","IXN","LU1316542783.SGD","LU0310799852.SGD","IE0005OL40V9.USD","QBY","LU0203201768.USD","LU2250418816.HKD","LU0048584097.USD","LU2125154935.USD","LU1242518857.USD","LU1923623000.USD","LU2168564149.EUR","GAMR","IE00BJJMRX11.SGD","LU1861220033.SGD","BK4170","SG9999015952.SGD","LU2125909593.SGD","LU0787776722.HKD","NVDW","LU0082616367.USD","LU0354030511.USD","LU1791710582.SGD","LU2750360997.AUD","LU1712237335.SGD","LU0345770308.USD","LU0642271901.SGD","LU0898699433.AUD","LU0942090050.USD","SG9999014559.SGD","LU2089985449.USD","LU1429558221.USD","LU0215105999.USD","ANV","LU0061474705.USD","LU0823434740.USD","LU0310800379.SGD","LU0256863811.USD","IE000W1ABFV2.USD","LU0347712357.USD","LU0077335932.USD","LU0943347566.SGD","USXF","LU0724617625.USD","LU2290526834.HKD","LU0107464264.USD","LU1400636574.HKD","CHAT","LU0390134368.USD","SG9999015358.SGD","IE0004445239.USD","ESLG","LU0210536198.USD","LU1923622291.USD","NVD2.UK","LU1868836591.USD","IE0001KFT4U8.USD","LU0061474960.USD","LU1880398471.USD","NVDQ","LU1642822529.SGD","IE0034235303.USD","BK4605","LU0795875086.SGD","BK4551","SGXZ81514606.USD","LU0965509010.AUD","IE00B3S45H60.SGD","IONX","NVD3.UK","LU2242650005.HKD","LU2491050071.SGD","SG9999014906.USD","IE000YTNTUN2.SGD","LU0234570918.USD","LU2237443895.HKD","LU1979441026.SGD","LU1551013342.USD","IE00BJLML261.HKD","LU1935043452.HKD","LU1852331112.SGD","LU2360107168.USD","SOXQ","LU1496350502.SGD","LU1037948897.HKD","LU2133065610.SGD","LU1934455194.USD","IE00BKDWB100.SGD","LU0265550359.USD","LU1571399168.USD","LU2244417387.USD","LU2237443465.HKD","LU2452424414.USD","WISE","LU1435385759.SGD","BK4612","LU0323240290.USD","LU2148611432.USD","LU0157215616.USD","HK0000914686.HKD","LU2236285917.USD","ABFL","LU1366333091.USD","LU2106854487.HKD","SMHX","VGT","LU2473716301.USD","LU2272731865.HKD","TRFK","IE000Q6AESB8.SGD","LU0053666078.USD","LU0320765059.SGD","LU0266013472.USD","LU2125909759.SGD","LU0348723411.USD","LU1791710400.SGD","LU1267930573.SGD","IE00BD6J9T35.USD","AGOX","LU2458330169.SGD","BK4587","LU2552382215.SGD","IE00BQXX3D17.EUR","LU0788109477.HKD","HK0000304797.USD","LU0056508442.USD","LU0198837287.USD","LU1202635105.USD","SG9999014567.USD","SG9999002224.SGD","LU1242518931.SGD","LU0965508806.USD","IE00B4JS1V06.HKD","LU2077746001.SGD","IOYY","LU2023251221.USD","NVDD","LU2028103732.USD","GB00BDT5M118.USD","BK4602","LU2247934214.USD","VT","LU0965509101.SGD","LU0861579265.USD","LU0175139822.USD","LU1988902786.USD","SG9999014914.USD","LU0444973449.USD","LU2860962120.EUR","CNEQ","LU1232071149.USD","LU1951198990.SGD","LU1868837300.USD","SGXZ31699556.SGD","LU1267930730.SGD","LU2047632596.USD","LU0106261372.USD","LU0094547139.USD","HK0000320223.HKD","LU0080751232.USD","LU0187121727.USD","LU3102509885.SGD","07388","LU1629891620.HKD","CHPX","LU2092627202.USD","HK0000304805.HKD","CLSE","LU2999663052.SGD","LU2361045086.USD","LU1116320901.HKD","LU2271345857.HKD","LU0210533765.USD","LU2403377893.USD","NVDS","LU0127658192.USD","LU0957808578.USD","IONL","IE00BN29S564.USD","LU2394011477.USD","TTEQ","IE0004445015.USD","LFGY","LU0689626769.HKD","LU1935042488.USD","LU1989764664.SGD","IE00BWXC8680.SGD","NVC","BK4529","QNTM","BK4550","LU1718418525.SGD","LU2083900584.USD","IETC","LU1699723380.USD","LU1548497426.USD","IE00BJJMRY28.SGD","LU0868494617.USD","LU2272731782.SGD","IONC","LU2471134523.USD","LU1992135472.HKD","LU0511384066.AUD","LU0234572021.USD","LU2237438978.USD","IE00BKVL7J92.USD","LU2430703178.SGD","LU2100268510.USD","IE00BK4W5L77.USD","LU0868494708.USD","LU0267386448.USD","IE00BQXX3C00.GBP","LU1821325948.USD","LU2264538146.SGD","SG9999001424.SGD","LU1035775433.USD","LU2433249047.HKD","LU2361044865.SGD","LU1861215975.USD","LU1803068979.SGD","LU2505996681.GBP","LU1551013425.SGD","XLK","IONZ","LU2552382058.USD","LU0823421416.USD","LU1815333072.USD","LU0006306889.USD","BK4567","SG9999015986.USD","IE0009356076.USD","LU1244550577.SGD","LU2505996509.AUD","NVD","JGRO","LU1127390331.HKD","LU2242649171.HKD","IE00B775H168.HKD","IE00B5TLWC47.USD","LU2111349929.HKD","LU1244550221.USD","TYLG","IE00BZ1G4Q59.USD","IE00B19Z9505.USD","LU1923622614.USD","NVDO","IE00BDCRKT87.USD","LU0138981039.USD","LU2023250330.USD","IE00BMPRXR70.SGD","LU0353189680.USD","SG9999018865.SGD","SGXZ23171101.USD","LU2360032135.SGD","LU1974910355.USD","LU1066051225.USD","SG9999015978.USD","LU0225283273.USD","ARTY","LU2463028550.USD","LU1670756490.USD","LU1623119135.USD","NVDB","QTUP","LU0823414478.USD","LU0238689110.USD","LU0158827781.USD","LU0889565833.HKD","LU1400636657.SGD","LU1069347547.HKD","LU2471134879.HKD","LU1366192091.USD","SG9999014542.SGD","LU0210528500.USD","3NVD.UK","BK4548","BK4588","LU2552382132.HKD","SOXX","LU0072462426.USD","LU2054465674.USD","LU2108987350.USD","LU2322448791.USD","LU1035773651.USD","NVDG","LU1066051811.HKD","LU0323239441.USD","LU2322448957.HKD","SG9999014880.SGD","LU1935043023.USD","LU2168563687.JPY","LU1935042991.SGD","LU2954938101.SGD","LU1732799900.SGD","LU1153585028.USD","FDTX","LU1989772840.SGD","IE00BQXX3F31.USD","LU0345768153.USD","LU0823421333.USD","NULC","LU0203202063.USD","IE0003U64NQ7.SGD","LU0683600562.USD","LU1119994496.HKD","IE0004086264.USD","LU0786609619.USD","LU2092937148.SGD","LU0820562030.AUD","FAI","SG9999018857.SGD","LU2211815571.USD","LU0276348264.USD","LU2237957902.USD","LU0342679015.USD","LU1815336760.USD","NVDS.UK","IE00BFSS7M15.SGD","LU1914381329.SGD","LU1003077747.HKD","LU1261432733.SGD","LU0345770993.USD","LU0640476718.USD","LU0466842654.USD","LU1814569148.SGD","LU0823434583.USD","LU0395794307.EUR","TTXU","LU2592432038.USD","LU0289961442.SGD","LU2087621335.USD","LU0143551892.USD","LU0820561909.HKD","LU2471134796.USD","LU2089283258.USD","BK4608","SGXZ51526630.SGD","LU2462591277.SGD","LU2125909247.SGD","LU2491049909.HKD","LU1732800096.USD","LU2125154778.USD","LU0708995401.HKD","LU2168564495.EUR","BK4527","IE0004091025.USD","SPTE","HK0000914660.USD","LU2237443549.SGD","IE0009G5SDU7.USD","LU1720051017.SGD","LU1934455277.USD","HK0000320264.USD","LU1935042215.USD","LU2461242641.AUD","HK0000532082.HKD","IE00BJTD4V19.USD","LU2430703251.USD","LU2471134952.CNY","LU2357305700.SGD","LU2491050154.USD","QBTS","SHOC","IE00B1BXHZ80.USD","AIFD","LU0211327993.USD","NVYY","LU2168564065.EUR","LU0726765562.USD","SOXY","LU0274383776.USD","LU2063271972.USD","SMH","LU1868836757.USD","LU2462157665.USD","NVDU","LU1066051498.USD","SNPE","LU0109391861.USD","LU1144417596.USD","LU2326559502.SGD","IE00B4YYXB79.USD","BK4532","SG9999014898.SGD","LU0096364046.USD","LU0170899867.USD","SGXZ99366536.SGD","BK4592","LU2279689827.SGD","LU0308772762.SGD","LU1400636491.USD","LU0069063385.USD","LU1037948541.HKD","BK4543","LU1084165304.USD","LU0323591593.USD","LU0553294199.USD","LU1839511570.USD","NVIW.SI","LU2896262040.SGD","IE000KEQY171.SGD","LU0661504455.SGD","LU2023250504.SGD","LU2750360641.GBP","07788","IE00BFSS8Q28.SGD","IE00BHPRN162.USD","IE00BMPRXN33.USD","LU0795875169.SGD","LU1064131342.USD","LU1244550494.USD","LU2381873111.SGD","BK4534","LU0823414551.USD","IE00B3SWFQ91.USD","LU0528227936.USD","LU1691799644.USD","HK0000306685.HKD","LU0345769128.USD","IE00BJTD4N35.SGD","LU2417539215.USD","LU0029864427.USD","LU2237443382.USD","IE000ITXATA3.USD","LU1145028129.USD","BK4581","IE00BMPRXQ63.HKD","EFIV","SGXZ80539844.SGD","SG9999015341.SGD","LU2756315318.SGD","IE00B19Z8W00.USD","LU0719512351.SGD","LU1989764748.USD","ESUM","LU0251132253.USD","LU0011850046.USD","LU2191332357.HKD","LU1804176565.USD","LU1645745479.HKD","LU1267930490.SGD","FTEC","QBTX","LU2347655156.SGD","LU0079474960.USD","LU0289960550.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668945699","title":"Quantum BioPharma Board Authorizes Class a Multiple-Voting Share Offering to Lift Control Stake to 75.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668945699","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668945699?lang=en_us&edition=fundamental","pubTime":"2026-09-18 03:13","pubTimestamp":1789672423,"startTime":"0","endTime":"0","summary":"Quantum BioPharma board authorizes Class A multiple-voting share offering to lift control stake to 75.27%Board action on Oct. 29, 2025 set up an offering of Class A Multiple Voting Shares to restore v","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL9nTjbs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNTM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668399456","title":"Quantum BioPharma Plans Debt Conversion at Conversion Price of CAD 4 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2668399456","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668399456?lang=en_us&edition=fundamental","pubTime":"2026-09-18 03:13","pubTimestamp":1789672416,"startTime":"0","endTime":"0","summary":"Quantum BioPharma plans debt conversion at conversion price of CAD 4 per shareQuantum BioPharma outlined terms for secured convertible debentures in a planned private placement, including quarterly ca","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL5Lx47n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNTM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668994566","title":"Quantum BioPharma Grants 7,692 Stock Options to Director Zapolin at C$ 6.6 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2668994566","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668994566?lang=en_us&edition=fundamental","pubTime":"2026-09-18 03:13","pubTimestamp":1789672405,"startTime":"0","endTime":"0","summary":"Quantum BioPharma grants 7,692 stock options to director Zapolin at C$ 6.6 per shareQuantum BioPharma cancelled 7,692 warrants held by director Michael (Zappy) Zapolin to buy Class B subordinate votin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL4DL6QJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNTM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668993499","title":"Quantum BioPharma (NASDAQ: QNTM) Announces that Rodman & Renshaw Initiates Coverage with Buy Rating, $8 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2668993499","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668993499?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662616,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, September 17th, 2026, FinanceWire Disseminated on behalf of Quantum BioPharma Ltd. and may include pai...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-announces-that-rodman-renshaw-initiates-coverage-with-buy-rating-8-price-target?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-announces-that-rodman-renshaw-initiates-coverage-with-buy-rating-8-price-target?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNTM",".IXIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668964186","title":"Rodman & Renshaw Initiates Quantum BioPharma Coverage with Buy Rating, US$ 8 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2668964186","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668964186?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:01","pubTimestamp":1789646497,"startTime":"0","endTime":"0","summary":"Rodman & Renshaw initiates Quantum BioPharma coverage with buy rating, US$ 8 targetRodman & Renshaw initiated coverage of Quantum BioPharma with a Buy rating.The firm set a US$ 8 price target.Coverage","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL4Pg746:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","SG9999014039.USD","IE00BKPKM429.USD","LU0314104364.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","BK4588","LU2210150020.SGD","BK4007","SG9999014005.SGD","BCDF","BK4585","BK4112","SG9999014021.USD","IE00B3QW5Z07.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","SG9999014013.SGD","QNTM","IE00BQXX3D17.EUR","NDAQ","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667268946","title":"Quantum BioPharma (NASDAQ: QNTM) to Present at 3rd Annual ArcStone-Kingswood Growth Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2667268946","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667268946?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488029,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, September 15th, 2026, FinanceWire Disseminated on behalf of Quantum BioPharma Ltd. and may include pai...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-to-present-at-3rd-annual-arcstone-kingswood-growth-summit?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-to-present-at-3rd-annual-arcstone-kingswood-growth-summit?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["03086","MNQmain","QQQA","NVIW.SI","NQmain","QYLG","QQQE","SQQQ","ONEQ","IYW","QNTM","QQQM","TQQQ","BK4007","QID","FTEC","NDX","GPIQ","TQQY",".IXIC","QQQY","TECS","QQQJ","JEPQ","QLD","PSQ","QDTE","QQQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642172","title":"Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642172","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642172?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473600,"startTime":"0","endTime":"0","summary":"TORONTO, Sept.  15, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FSE: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3362028/0/en/quantum-biopharma-to-attend-the-arcstone-kingswood-growth-summit-2026-in-toronto.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1668664300.SGD","LU0098860793.USD","LCID","LU0528227936.USD","LU0557290698.USD","LCDL","IE00B775SV38.USD","LU2347655156.SGD","LU1720051017.SGD","LU0106831901.USD","QNTM","BK4585","LU1244550494.USD","LU1548497426.USD","LU2133065610.SGD","LU0390134368.USD","LU2089283258.USD","LU1162221912.USD","LU1988902786.USD","LU2089284900.SGD","LU0795875169.SGD","KBWB","LU0158827948.USD","LU0225283273.USD","BK4555","BK4534","LU0210528500.USD","LU1064131342.USD","LU2487616109.SGD","LCIZ","LU2357305700.SGD","IE00B3S45H60.SGD","LU0882574139.USD","BK4127","LU0053666078.USD","LU2023251221.USD","BK4516","LU2264538146.SGD","LU1074936037.SGD","LU0267386448.USD","LU1244550221.USD","IAI","BK4588","LU2111349929.HKD","LU0971096721.USD","BK4504","LU1989772923.USD","LU1791710582.SGD","LU1732799900.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666161","title":"Stray Alert on Quantum BioPharma Withdrawn","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666161","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666161?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:47","pubTimestamp":1789390050,"startTime":"0","endTime":"0","summary":"ADVISORY-Stray alert on Quantum BioPharma withdrawnAn alert from NetworkNewsAudio announcing an audio press release about FDA clearance of a clinical trial involving Quantum BioPharma was inadvertentl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA2MG65F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNTM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.quantumbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.1542},{"period":"1month","weight":-0.2312},{"period":"3month","weight":-0.2107},{"period":"6month","weight":-0.1474},{"period":"1year","weight":-0.8336},{"period":"ytd","weight":-0.6356}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":0.0115},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.0837},{"period":"1year","weight":0.1621},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.01855},{"month":2,"riseRate":0.714286,"avgChangeRate":0.114242},{"month":3,"riseRate":0.285714,"avgChangeRate":0.061101},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.067135},{"month":5,"riseRate":0.285714,"avgChangeRate":0.083426},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.039168},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.044147},{"month":8,"riseRate":0.571429,"avgChangeRate":-0.065819},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.070977},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.15398},{"month":11,"riseRate":0.333333,"avgChangeRate":0.040234},{"month":12,"riseRate":0,"avgChangeRate":-0.179121}],"exchange":"NASDAQ","name":"Quantum Biopharma Ltd.","nameEN":"Quantum Biopharma Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Quantum Biopharma Ltd.(QNTM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Quantum Biopharma Ltd.(QNTM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Quantum Biopharma Ltd.,QNTM,Quantum Biopharma Ltd.股票,Quantum Biopharma Ltd.股票老虎,Quantum Biopharma Ltd.股票老虎国际,Quantum Biopharma Ltd.行情,Quantum Biopharma Ltd.股票行情,Quantum Biopharma Ltd.股价,Quantum Biopharma Ltd.股市,Quantum Biopharma Ltd.股票价格,Quantum Biopharma Ltd.股票交易,Quantum Biopharma Ltd.股票购买,Quantum Biopharma Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Quantum Biopharma Ltd.(QNTM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Quantum Biopharma Ltd.(QNTM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction